Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of
disability. While there continues to be expansive research in posttraumatic stress disorder …

Current medication for anxiety disorders is suboptimal in terms of efficiency and tolerability,
highlighting the need for improved drug treatments. In this review an overview of drugs …

Introduction: Generalized anxiety disorder (GAD) is a common form of anxiety disorder.
Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake …

Anxiety disorders are the most common mental diseases. Anxiety and the associated
physical symptoms may disturb social and occupational life and increase the risk of somatic …

In this review, the author examines the evidence for psychopharmacologic treatments
among adults for generalized anxiety disorder, panic disorder, and social anxiety disorder …

Generalized anxiety disorder (GAD) is a significant and common mental illness with a
lifetime prevalence of 3.7%. Regardless of the complexity of treatment decisions for GAD …

The guide recommends SSRI and SNRI drugs as first-line treatments for generalized anxiety
disorder (GAD). Therefore, we aimed to update the evidence using network meta-analysis …

Despite the effectiveness and high tolerability of vilazodone (VLZ) as an antidepressant, its
use is still limited due to its poor solubility and food dependent absorption. This study aims to …

Subthreshold psychiatric disorders do not fully meet the diagnostic criteria of syndromal
disorders but may be associated with comparable disability. To investigate the anxiolytic …

BACKGROUND: Panic disorder (PD) is a devastating illness, with numerous patients
experiencing significant functional disability and many not achieving full remission with first …